Cryptococcosis in Solid-Organ, Hematopoietic Stem Cell, and Tissue Transplant Recipients: Evidence-Based Evolving Trends

摘要: The impact of current transplantation practices on the characteristics cryptococcosis in solid-organ transplant recipients is not well defined. incidence cryptococcal disease among has remained unchanged; however, patients are less likely to present with central nervous system or disseminated and more have limited lungs. Additionally, lipid formulations amphotericin B now used frequently, whereas their use combination flucytosine decreased. overall mortality significantly improved era. Renal failure remains associated poor outcome, a higher survival rate. Despite rare infectious complication, certain peculiar attributes hematopoietic stem cell tissue warrant recognition.